Search research articles
Contact Us
Filters
Showing results (41-50 of 131) with videos related to
Page
of 14
Sort By:
Harvard Review of Psychiatry
|
August 30, 2005
Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia?
Jonathan D Picker, Joseph T Coyle
Current Opinion in Pharmacology
|
December 27, 2014
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond
Darrick T Balu, Joseph T Coyle
Advances in Pharmacology (San Diego, Calif.)
|
February 8, 2018
The Role of Serine Racemase in the Pathophysiology of Brain Disorders
Joseph T Coyle, Darrick T Balu
Translational Psychiatry
|
October 10, 2025
Novel electroencephalographic biomarkers for the prediction of responders to an experimental glutamatergic agent in patients with schizophrenia
Peter J Siekmeier, Joseph T Coyle
Nature Reviews. Drug Discovery
|
March 3, 2026
Author Correction: Novel drug treatments for schizophrenia
Joseph T Coyle, Steven M Paul
Neurochemical Research
|
March 20, 2020
D-Serine, the Shape-Shifting NMDA Receptor Co-agonist
Joseph T Coyle, Darrick Balu, Herman Wolosker
Annals of the New York Academy of Sciences
|
December 20, 2003
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia
Joseph T Coyle, Guochuan Tsai, Donald Goff
Brain Research
|
November 10, 2020
Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum
Shunsuke Takagi, Darrick T Balu, Joseph T Coyle
Trends in Neurosciences
|
July 31, 2017
Astroglial Versus Neuronal D-Serine: Check Your Controls!
Herman Wolosker, Darrick T Balu, Joseph T Coyle
Trends in Neurosciences
|
October 16, 2016
The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis
Herman Wolosker, Darrick T Balu, Joseph T Coyle
Page
of 14
Search research articles
Search
Showing results (41-50 of 131) with videos related to
Sort By:
Page
of 14
Harvard Review of Psychiatry
|
August 30, 2005
Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia?
Jonathan D Picker, Joseph T Coyle
Current Opinion in Pharmacology
|
December 27, 2014
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond
Darrick T Balu, Joseph T Coyle
Advances in Pharmacology (San Diego, Calif.)
|
February 8, 2018
The Role of Serine Racemase in the Pathophysiology of Brain Disorders
Joseph T Coyle, Darrick T Balu
Translational Psychiatry
|
October 10, 2025
Novel electroencephalographic biomarkers for the prediction of responders to an experimental glutamatergic agent in patients with schizophrenia
Peter J Siekmeier, Joseph T Coyle
Nature Reviews. Drug Discovery
|
March 3, 2026
Author Correction: Novel drug treatments for schizophrenia
Joseph T Coyle, Steven M Paul
Neurochemical Research
|
March 20, 2020
D-Serine, the Shape-Shifting NMDA Receptor Co-agonist
Joseph T Coyle, Darrick Balu, Herman Wolosker
Annals of the New York Academy of Sciences
|
December 20, 2003
Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia
Joseph T Coyle, Guochuan Tsai, Donald Goff
Brain Research
|
November 10, 2020
Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum
Shunsuke Takagi, Darrick T Balu, Joseph T Coyle
Trends in Neurosciences
|
July 31, 2017
Astroglial Versus Neuronal D-Serine: Check Your Controls!
Herman Wolosker, Darrick T Balu, Joseph T Coyle
Trends in Neurosciences
|
October 16, 2016
The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis
Herman Wolosker, Darrick T Balu, Joseph T Coyle
Page
of 14